As reported elsewhere, the median baseline CRP levels for ALPHA 18 and BETA 19 were ≤1.90 mg/L among the four intervention groups, below the 3.0 mg/L threshold considered high risk for diabetes and cardiovascular disease [57, 58]. Here, CRP is linked to cardiovascular disorder.